Impacts of person-centred integrated chronic heart failure and palliative home care on pharmacological heart failure treatment: A substudy of a randomised trial

BMJ Supportive and Palliative Care

Volumn 9, Issue 1, 2019, Pages

  Markgren, Rickard ^a   Brännström, Margareta ^b   Lundgren, Claes ^c   Boman, Kurt ^b  

^a ST GÖRAN S HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c Skelleftea Hospital   (Sweden)

Author keywords

Chronic heart failure; Palliative care; Person centred; Pharmacology

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOTONIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MINERALOCORTICOID ANTAGONIST;

AGED; CHRONIC DISEASE; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FEMALE; HEART FAILURE; HOME CARE; HOSPITALIZATION; HUMAN; MALE; PALLIATIVE NURSING; PALLIATIVE THERAPY; PATIENT CARE; PROCEDURES; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STANDARDS; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOTONIC AGENTS; CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; FEMALE; HEART FAILURE; HOME CARE SERVICES; HOSPICE AND PALLIATIVE CARE NURSING; HOSPITALIZATION; HUMANS; MALE; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PALLIATIVE CARE; PATIENT-CENTERED CARE; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 85061865428     PISSN: 2045435X     EISSN: 20454368     Source Type: Journal    
DOI: 10.1136/bmjspcare-2015-000894     Document Type: Article

References (23)

1. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;29:2388-442.
2. National Clinical Guideline Centre. Chronic heart failure: the management of chronic heart failure in adults in primary and secondary care. London: National Clinical Guideline Centre, 2010. http://guidance.nice.org.uk/CG108/Guidance/pdf/English
3. Scottish Intercollegiate Guidelines Network. Management of Chronic Heart Failure. Publication Number 95. Edinburgh: SIGN, 2007. http://www.sign.ac.uk
4. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-17
5. [No authors listed]. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987;316:1429-35
6. [No authors listed]. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
7. Brännström M, H ägglund L, et al. Unequal care for dying patients in Sweden: A comparative registry study of deaths from heart disease and cancer. Eur J Cardiovasc Nurs 2012;11:454-9.
8. Brännström M, Ekman I, Norberg A, et al. Living with severe chronic heart failure in palliative advanced home care. Eur J Cardiovasc Nurs 2006;5:295-302.
9. Jonsson A, Edner M, Alehagen U, et al. Heart failure registry: A valuable tool for improving the management of patients with heart failure. Eur J Heart Fail 2010;12:25-31.
10. Falk K, Swedberg K, Gaston-Johansson F, et al. Fatigue and anaemia in patients with chronic heart failure. Eur J Heart Fail 2006;8:744-9.
11. Brännström M, Boman K. Effects of person-centred and integrated chronic heart failure and palliative home care. PREFER: A randomized controlled study. Eur J Heart Fail 2014;16:1142-51.
12. Thorvaldsen T, Lund LH. [More patients with heart failure should be referred to a specialist. New simplified strategy provides support for assessment]. Lakartidningen 2014;111:731.
13. McMurray JJ. Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors? Eur Heart J 1998;19(Suppl L):L15-21.
14. Jaarsma T, Beattie JM, Ryder M, et al. Palliative care in heart failure: A position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2009;11:433-43.
15. Brännström M, Boman K. A new model for integrated heart failure and palliative advanced homecare-rationale and design of a prospective randomized study. Eur J Cardiovasc Nurs 2013;12:269-75.
16. Ekman I, Swedberg K, Taft C, et al. Person-centered care- ready for prime time. Eur J Cardiovasc Nurs 2011;10:248-51.
17. Ternestedt B. A dignified death and identity-promoting care. In: Nordenfelt L, ed. Dignity in care for older people. 2010:146-65.
18. McMurray J, Cohen-Solal A, Dietz R, et al. Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice. Eur J Heart Fail 2005;7:710-21.
19. Tamirisa KP, Aaronson KD, Koelling TM. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure. Am Heart J 2004;148:971-8.
20. Svensson M, Gustafsson F, Galatius S, et al. How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure? J Card Fail 2004;10:297-303.
21. Hobbs FD. Management of heart failure: evidence versus practice. Does current prescribing provide optimal treatment for heart failure patients? Br J Gen Pract 2000;50:735-42.
22. Strömberg A, Dahlström U. Heart failure clinics have decreased mortality and hospitalisation rates in Sweden. Eur Heart J 2004;25:1368-9; author reply
23. Ekman I, Wolf A, Olsson LE, et al. Effects of person-centred care in patients with chronic heart failure: the PCC-HF study. Eur Heart J 2012;33:1112-19.